Allowance provides broad IP protection for drug-delivery platform and extends market exclusivity for two lead clinical assets currently in Phase 2 trials PITTSBURGH, Oct. 15, 2024 (GLOBE NEWSWIRE) -- ...

Chalet Tan is a professor in the Department of Pharmaceutical Sciences at the University of Tennessee Health Science Center (TN, USA). Her lab focuses on targeted drug delivery, specifically biologics ...

Lipella Pharmaceuticals (LIPO) announced that U.S. Patent No. 12,138,345 for its proprietary liposomal drug delivery platform will be officially issued by the U.S. Patent and Trademark Office, or ...

Modern cancer therapies have resulted in higher survival rates for victims of this dread disease, in many cases. However, their generic mode of delivery and action is associated with greater adverse ...

Liposomes were formulated for the first time at the beginning of the 1960s, exosomes were named as such at the beginning of the 1980s. Liposomes have been extensively explored as a drug delivery ...